Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

• Autores principales: Andre Bredthauer (Autor), Manuel Kopfmueller (Autor), Michael Gruber (Autor), Sophie-Marie Pfaehler (Autor), Karla Lehle (Autor), Walter Petermichl (Autor), Timo Seyfried (Autor), Diane Bitzinger (Autor), Andreas Redel (Autor)
• Formato: Libro
• Publicado: Hindawi-Wiley, 2020-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction. Anticoagulants such as argatroban and heparins (low-molecular-weight and unfractionated) play an immense role in preventing thromboembolic complications in clinical practice. Nevertheless, they can also have a negative effect on the immune system. This study is aimed at investigating t...